US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 17, 2020 (6 years ago)

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurity/Degradation Specifications

What was recalled

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68

Recalling firm
Ascend Laboratories LLC
NDC code
67877-545-68
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0179-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cephalexin recalls

See all